LUONGO, Livio
 Distribuzione geografica
Continente #
NA - Nord America 3.121
EU - Europa 3.039
AS - Asia 855
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 7.029
Nazione #
US - Stati Uniti d'America 3.116
IE - Irlanda 973
IT - Italia 638
CN - Cina 545
UA - Ucraina 404
GB - Regno Unito 337
DE - Germania 306
TR - Turchia 140
SG - Singapore 114
FI - Finlandia 104
SE - Svezia 92
GR - Grecia 90
FR - Francia 32
VN - Vietnam 24
BE - Belgio 22
CZ - Repubblica Ceca 18
BR - Brasile 9
JP - Giappone 7
LB - Libano 7
NL - Olanda 7
ES - Italia 5
TW - Taiwan 5
CA - Canada 4
DK - Danimarca 4
IN - India 4
IR - Iran 4
CL - Cile 2
PK - Pakistan 2
RO - Romania 2
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
CH - Svizzera 1
EU - Europa 1
HK - Hong Kong 1
MK - Macedonia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
RU - Federazione Russa 1
Totale 7.029
Città #
Dublin 969
Chandler 630
Jacksonville 579
Beijing 158
Bremen 135
Princeton 131
Ann Arbor 114
Wilmington 111
Medford 110
Boardman 108
Ashburn 105
Dearborn 97
Roxbury 89
Cava 86
Naples 83
Caserta 70
Hefei 70
Woodbridge 70
Singapore 69
San Mateo 48
Nanjing 47
New York 42
Kunming 39
Mugnano di Napoli 37
Cambridge 35
Des Moines 32
Napoli 28
Jinan 27
Dong Ket 24
Houston 24
Brussels 22
Mountain View 21
Düsseldorf 20
Brno 18
Guangzhou 17
Munich 17
Rome 16
Norwalk 15
Helsinki 14
Nanchang 13
Shenyang 13
Hanover 12
Hebei 12
Auburn Hills 11
Milan 11
Redwood City 10
Venice 10
Ningbo 9
Zhengzhou 9
Los Angeles 8
Aversa 7
Falls Church 6
Izmir 6
Paris 6
Santa Maria Capua Vetere 6
Shanghai 6
Shaoxing 6
Xian 6
Aiello del Sabato 5
Campinas 5
Chengdu 5
Hangzhou 5
Lappeenranta 5
Mcallen 5
Modena 5
Taipei 5
Chaoyang 4
Elora 4
Florence 4
Frederiksberg 4
Lanzhou 4
Pioltello 4
Tappahannock 4
Altamura 3
Amsterdam 3
Andover 3
Baotou 3
Bonea 3
Centrale 3
Changsha 3
Chongqing 3
Fuzhou 3
Grafing 3
Gunzenhausen 3
Huzhou 3
Marigliano 3
Nuremberg 3
Parma 3
Poggiomarino 3
Quzhou 3
Seattle 3
Teano 3
Verona 3
Xi'an 3
Afragola 2
Battipaglia 2
Bolzano 2
Buffalo 2
Calviá 2
Camerino 2
Totale 4.637
Nome #
SOSTITUZIONE BIOISOSTERICA DEL GRUPPO AMMIDICO DI 4-CHINOLON-3-CARBOSSAMIDI6-SOSTITUITE:LIGANDI CB2 POTENTI E SELETTIVI PROVVISTI DI MIGLIOR PROFILO CHIMICO-FISICO . 128
Cannabinoid receptor 2 as anti-obesity target: inflammation, fat storage and browning modulation. 105
USO DEI BISFOSFONATI PER LA PREPARAZIONE DI FORMULAZIONI FARMACEUTICHE PER IL TRATTAMENTO DEI SINTOMI ASSOCIATI A DOLORE NEUROPATICO 101
D-Aspartate drinking solution alleviates pain and cognitive impairment in neuropathic mice. 99
MMPIP, an mGluR7-selective negative allosteric modulator, alleviates pain and normalizes affective and cognitive behavior in neuropathic mice 98
1-(2′,4′-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihy droindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice 94
Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice 93
Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action in vivo. 92
Chalcone derivatives activate and desensitize the transient receptor potential ankyrin 1 cation channel, subfamily A, member 1 TRPA1 ion channel: structure-activity relationships in vitro and anti-nociceptive and anti-inflammatory activity in vivo 91
1-(2',4'-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice. Neurobiol Dis. 2010 Jan;37(1):177-85. Epub 2009 Oct 3. PubMed PMID: 19804829 86
Endocannabinoid Research Group (ERG), Italy. The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy. 84
Neuroimmune-driven neuropathic pain establishment: A focus on gender differences 84
Dorsal striatum metabotropic glutamate receptor 8 affects nocifensive responses and rostral ventromedial medulla cell activity in neuropathic pain conditions. 81
PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice. 80
The antinociceptive effect of 2-chloro-2'-C-methyl-N6-cyclopentyladenosine (2'-Me-CCPA), a highly selective adenosine A1 receptor agonist, in the rat 79
Age-Related Changes in D-Aspartate Oxidase Promoter Methylation Control Extracellular D-Aspartate Levels and Prevent Precocious Cell Death during Brain Aging 78
Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: Involvement of the CB2 receptor 78
Palmitoylethanolamide reduces neuropsychiatric behaviors by restoring cortical electrophysiological activity in a mouse model of mild traumatic brain injury 75
Involvement of subtype 1 metabotropic glutamate receptors in apoptosis and caspase-7 over-expression in spinal cord of neuropathic rats 74
Changes in cannabinoid receptor subtype 1 activity and interaction with metabotropic glutamate subtype 5 receptors in the periaqueductal gray-rostral ventromedial medulla pathway in a rodent neuropathic pain model. 74
EP1 receptor within the ventrolateral periaqueductal grey controls thermonociception and rostral ventromedial medulla cell activity in healthy and neuropathic rat 73
Design and Synthesis of New Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channel Modulators: Identification, Molecular Modeling Analysis, and Pharmacological Characterization of the N-(4-Hydroxy-3-methoxybenzyl)-4-(thiophen-2-yl)butanamide, a Small Molecule Endowed with Agonist TRPV1 Activity and Protective Effects against Oxidative Stress. 73
Salvinorin A reduces mechanical allodynia and spinal neuronal hyperexcitability induced by peripheral formalin injection. 73
Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain. 73
The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats. 72
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties. 72
Exposure to allergen causes changes in nts neural activities after intratracheal capsaicin application, in endocannabinoid levels and in the glia morphology of nts 72
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain 71
Metabotropic glutamate receptor subtype 7 in the dorsal striatum oppositely modulates pain in sham and neuropathic rats 71
Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways 70
Effects of intra-ventrolateral periaqueductal grey palmitoylethanolamide on thermoceptive threshold and rostral ventromedial medulla cell activity 70
5'-Chloro-5'-deoxy-(±)-ENBA, a potent and selective adenosine A(1) receptor agonist, alleviates neuropathic pain in mice through functional glial and microglial changes without affecting motor or cardiovascular functions. Molecules. 70
The 17-β-oestradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression. 69
Intraperiaqueductal gray glycine and D-serine exert dual effects on rostral ventromedial medulla ON- and OFF-cell activity and thermoceptive threshold in the rat 68
Uso di bifosfonati per la preparazione di formulazioni farmaceutiche per il trattamento dei sintomi associati a dolore neuropatico. 68
The A1 adenosine receptor as a new player in microglia physiology 66
PKCβII-mediated cross-talk of TRPV1/CB2 modulates the glucocorticoid-induced osteoclast overactivity 66
The genetic ablation or pharmacological inhibition of TRPV1 signalling is beneficial for the restoration of quiescent osteoclast activity in ovariectomized mice. 65
The cannabinoid receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention. 65
2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into play 64
The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats 64
Role of reactive oxygen species and spinal cord apoptotic genes in the development of neuropathic pain 64
Effect of Prolonged Moderate Exercise on the Changes of Nonneuronal Cells in Early Myocardial Infarction. 64
The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy 63
Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity 63
Role of metabotropic glutamate receptor 1 in the basolateral amygdala-driven prefrontal cortical deactivation in inflammatory pain in the rat 62
Palvanil, a non-pungent capsaicin analogue, inhibits inflammatory and neuropathic pain with little effects on bronchopulmonary function and body temperature. 62
Contribution of sensory nerves to LPS-induced hyperresponsiveness of human isolated bronchi. 61
Intra-Periaqueductal Gray glycine and D-serine exert dual effects on the Rostral Ventromedial Medulla ON and OFF cell activity and thermal threshold in the rat 61
The 17-estradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression 61
Investigations on the 4-quinolone-3-carboxylic acid motif part 5: modulation of the physicochemical profile of a set of potent and selective cannabinoid-2 receptor ligands through a bioisosteric approach 61
d-Aspartic acid ameliorates painful and neuropsychiatric changes and reduces β-amyloid Aβ1-42 peptide in a long lasting model of neuropathic pain. 61
Effects of a metabotropic glutamate receptor subtype 7 negative allosteric modulator in the periaqueductal grey on pain responses and rostral ventromedial medulla cell activity in rat 60
Iron overload causes osteoporosis in Thalassemia Major patients through interaction with TRPV1 channels. 60
Palmitoylethanolamide reduces formalin-induced neuropathic-like behaviour through spinal glial/microglial phenotypical changes in mice 60
CB2 and TRPV1 receptors oppositely modulate in vitro human osteoblast activity 60
Transient receptor potential vanilloid type 1 and pain development. 58
Moving towards supraspinal TRPV1 receptors for chronic pain relief 57
Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice 57
Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice. 57
5'-C-Ethyl-tetrazolyl-N(6)-substituted adenosine and 2-chloro-adenosine derivatives as highly potent dual acting A1 adenosine receptor agonists and A3 adenosine receptor antagonists. 57
Altered gut microbiota and endocannabinoid system tone in vitamin D deficiency-mediated chronic pain. 57
Behavioral, Biochemical and Electrophysiological Changes in Spared Nerve Injury Model of Neuropathic Pain 57
Effects of metabolites of the analgesic agent dipyrone (metamizol) on rostral ventromedial medulla cell activity in mice. 56
Nociception modulation by supraspinal group III metabotropic glutamate receptors 56
d-Aspartate oxidase influences glutamatergic system homeostasis in mammalian brain 55
The galactosylation of N()-nitro-L-arginine enhances its anti-nocifensive or anti-allodynic effects by targeting glia in healthy and neuropathic mice 55
Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice 55
Effects of URB597, an inhibitor of fatty acid amide hydrolase (FAAH), on analgesic activity of paracetamol. 54
Design, synthesis, and pharmacological characterization of indol-3-ylacetamides, indol-3-yloxoacetamides, and indol-3-ylcarboxamides: potent and selective CB2 cannabinoid receptor inverse agonists. 54
Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states. 54
Pharmacological activity of a Bv8 analogue modified in position 24. 53
Spinal changes associated with mechanical hypersensitivity in a model of Guillain-Barré syndrome 53
Metabotropic glutamate receptor subtype 8 in the amygdala modulates thermal threshold, neurotransmitter release, and rostral ventromedial medulla cell activity in inflammatory pain. 53
Role of endocannabinoids in neuron-glial crosstalk 53
Allodynia Lowering Induced by Cannabinoids and Endocannabinoids (ALICE) 53
Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats. 51
Exploring the Role of N(6)-Substituents in Potent Dual Acting 5'-C-Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice ∇ 51
Relationship between blood lactate and cortical excitability between taekwondo athletes and non-athletes after hand-grip exercise 50
Chemotherapy-induced pain is promoted by enhanced spinal adenosine kinase levels via astrocyte-dependent mechanisms. 50
The role of cannabinoid receptors in the descending modulation of pain 49
Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid-neurotrophin interactions. 49
Effects of URB597, an inhibitor of fatty acid amide hydrolase (FAAH), on analgesic activity of paracetamol. Neuro Endocrinol Lett. 2010;31(4):507-11. PubMed PMID: 20802454 48
Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB1 R signaling and anxiety-like behavior. 48
The Modulation of Pain by Metabotropic Glutamate Receptors 7 and 8 in the Dorsal Striatum. 48
New Insights on Neuropathic Pain Mechanisms as a Source for Novel Therapeutical Strategies 47
Platelet-rich plasma exerts antinociceptive activity by a peripheral endocannabinoid-related mechanism 47
TRPV1-Dependent and -Independent Alterations in the Limbic Cortex of Neuropathic Mice: Impact on Glial Caspases and Pain Perception 46
Long-term neuropathic pain behaviors correlate with synaptic plasticity and limbic circuit alteration: a comparative observational study in mice 46
Orexin-A and Endocannabinoid Activation of the Descending Antinociceptive Pathway Underlies Altered Pain Perception in Leptin Signaling Deficiency. 45
Celecoxib Prevents Cognitive Impairment and Neuroinflammation in Soluble Amyloid β-treated Rats 45
Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist. 43
Investigations on the 4-quinolone-3-carboxylic acid motif. 4. Identification of new potent and selective ligands for the cannabinoid type 2 receptor with diverse substitution patterns and antihyperalgesic effects in mice. 42
Adenosine Metabotropic Receptors in Chronic Pain Management 42
Prostamide F2α receptor antagonism combined with inhibition of FAAH may block the pro-inflammatory mediators formed following selective FAAH inhibition 41
Treatment With 2-Pentadecyl-2-Oxazoline Restores Mild Traumatic Brain Injury-Induced Sensorial and Neuropsychiatric Dysfunctions 41
PEA-OXA ameliorates allodynia, neuropsychiatric and adipose tissue remodeling induced by social isolation. 41
Vitamin d deficiency induces chronic pain and microglial phenotypic changes in mice 40
2-Pentadecyl-2-oxazoline ameliorates memory impairment and depression-like behaviour in neuropathic mice: possible role of adrenergic alpha2- and H3 histamine autoreceptors. 40
null 39
Totale 6.345
Categoria #
all - tutte 26.599
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.599


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.197 118 101 9 29 109 112 382 178 69 39 40 11
2020/2021974 59 16 110 42 113 16 222 96 22 109 118 51
2021/2022967 64 14 11 14 274 21 23 26 43 133 79 265
2022/20232.318 149 52 42 247 313 203 9 174 1.027 19 40 43
2023/2024836 81 42 31 52 238 53 16 113 8 5 44 153
2024/202527 27 0 0 0 0 0 0 0 0 0 0 0
Totale 7.413